Drugs With the Most Patents

Number of drug patents per pharmaceutical drug

This chart shows the pharmaceutical drugs with the most patents still in force.

The number of patents covering a drug can be indicative of the value of a drug — more valuable drugs justify the substantial expense of building and maintaining large patent portfolios — but they can also be indicative of a company's legal or R&D acumen.

One clear way to keep competitors at bay is to surround key drugs with a web of strong patents, making it unlikely there will be any way to work around patents or invalidate a sufficient number of them. A large patent portfolio can also indicate strong, innovation-oriented R&D, with a focus on securing IP.

The drugs with the most unexpired patents are AFREZZA, REVLIMID, STIOLTO RESPIMAT, STRIVERDI RESPIMAT, VASCEPA, XIFAXAN, PROMACTA, AUVI-Q, EVZIO, and BYDUREON PEN.

Back to Pharmaceutical Patent Infographics

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Copyright 2002-2016 thinkBiotech LLC
ISSN: 2162-2639

Connect with Social Media:

`abc